Published in Drug Law Weekly, March 22nd, 2005
These are patients who haven't benefited from other therapies and have few options left. But testing new treatments on them has been criticized by some who feel the patients are given false hope, since previous reviews showed they only worked in about 4% to 6% of patients.
However, this latest and largest study found that about 11% were helped by experimental treatment, and in some cases as many as 27% were better off.
"The numbers aren't as...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.